Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers
Rebecca Lock(Brigham and Women's Hospital), Karen Cichowski(Brigham and Women's Hospital)
Cited by 43
Related Papers
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
|Journal of Clinical Investigation|2023|20
USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities
|Cell Reports Medicine|2023|12